A recent article in The Motley Fool talks about the fear and scrutiny that medical companies face in getting products approved. The writer suggests evolving instead of complaining. Some of the strategies suggested include focusing more on non-regulated technology if possible, playing with smaller technologies not requiring deep pockets of investments, think outside the U.S., and lastly being lucky enough to find a late stage company that has the potential to get some more capital before it dies. I guess these suggestions will help but does it really make anyone feel better???
Unrelated, medical device companies actually saw a modest growth in 2010. You probably couldn’t tell by the news. Acquisitions have helped fuel the movement with a Maryland based research firm estimating the growth as much as 6% and projecting the $305 billion market should continue to see this type of growth with the aging population and continued acquisition activity.